Levi & Korsinsky Notifies Neumora Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - NMRA
Portfolio Pulse from
Law firm Levi & Korsinsky has filed a class action lawsuit against Neumora Therapeutics (NMRA) alleging false statements and concealment regarding their Phase Two clinical trials for Navacaprant, a therapeutic candidate for Major Depressive Disorder (MDD). The lawsuit claims the company manipulated trial inclusion criteria and lacks adequate data to predict Phase Three study results.
March 21, 2025 | 4:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Class action lawsuit alleges misrepresentation of clinical trial data, which could negatively impact investor confidence and stock performance.
The lawsuit directly challenges Neumora's clinical trial integrity, which could lead to investor uncertainty, potential financial penalties, and reduced market confidence in the company's drug development process.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100